2013-01 | Effect of n-3 polyunsaturated fatty acid supplementation in patients with rheumatoid arthritis: a 16-week randomized, double-blind, placebo-controlled, parallel-design multicenter study in Korea | 최찬범 |
2013-06 | EFFECTS OF EARLY DIAGNOSIS ON DISEASE ACTIVITY AND FUNCTIONAL DISABILITY IN RHEUMATOID ARTHRITIS | 최찬범 |
2019-08 | Eosinophilic Granulomatosis with Polyangiitis: Experiences in Korean Patients | 최찬범 |
2012-08 | Evaluation of disease activity indices in Korean patients with rheumatoid arthritis | 최찬범 |
2015-03 | Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents | 최찬범 |
2013-10 | Evaluation Of The Usefulness Of Interferon-Gamma Release Assays and Tuberculin Skin Test For Detection Of Latent Mycobacterium Tuberculosis Infection In Korean Rheumatic Patients With Biologic Agents. | 최찬범 |
2015-11 | Factors Associated with the Use of Complementary and Alternative Medicine for Korean Patients with Rheumatoid Arthritis | 최찬범 |
2019-07 | Factors associated with time to diagnosis from symptom onset in patients with early rheumatoid arthritis | 최찬범 |
2016-12 | Factors Contributing to Discordance between the 2011 ACR/EULAR Criteria and Physician Clinical Judgment for the Identification of Remission in Patients with Rheumatoid Arthritis | 최찬범 |
2013-02 | Factors Influencing Discrepancies Between the QuantiFERON-TB Gold in Tube Test and the Tuberculin Skin Test in Korean Patients with Rheumatic Diseases | 최찬범 |
2019-01 | Fate of Abstracts Presented at the Korean College of Rheumatology Annual Scientific Meetings | 최찬범 |
2016-02 | The frequency of and risk factors for osteoporosis in Korean patients with rheumatoid arthritis | 최찬범 |
2020-07 | Genome-wide association study in a Korean population identifies six novel susceptibility loci for rheumatoid arthritis | 최찬범 |
2011-12 | Genome-Wide Association Study of Rheumatoid Arthritis in Koreans | 최찬범 |
2015-08 | Glucocorticoid Use in Patients With Systemic Lupus Erythematosus: Association Between Dose and Health Care Utilization and Costs | 최찬범 |
2015-03 | High-density genotyping of immune loci in Koreans and Europeans identifies eight new rheumatoid arthritis risk loci | 최찬범 |
2013-06 | HYPERTENSION AND ITS INFLUENCE ON CARDIOVASCULAR RISK AND RA OUTCOMES | 최찬범 |
2012-12 | Impact of comorbidities on TNF inhibitor persistence in rheumatoid arthritis patients: an analysis of Korean National Health Insurance claims data | 최찬범 |
2017-07 | Impact of early diagnosis on functional disability in rheumatoid arthritis | 최찬범 |
2017-10 | Impact of interstitial lung disease on mortality of patients with rheumatoid arthritis | 최찬범 |
2013-06 | IMPACTS OF IMMEDIATE CHANGES IN DMARDS ON OUTCOMES IN RHEUMATOID ARTHRITIS WITH MODERATE-TO-SEVERE ACTIVITY | 최찬범 |
2014-08 | Improving Participation in Clinical Trials of Novel Therapies: Going Back to Basics | 최찬범 |
2016-02 | Imputing Variants in HLA-DR Beta Genes Reveals That HLA-DRB1 Is Solely Associated with Rheumatoid Arthritis and Systemic Lupus Erythematosus | 최찬범 |
2014-06 | INCIDENCE AND RISK FACTORS FOR FRACTURES IN PATIENTS WITH RHEUMATOID ARTHRITIS | 최찬범 |
2016-09 | Incidence and risk factors of fractures in patients with rheumatoid arthritis: an Asian prospective cohort study | 최찬범 |
2016-03 | Influence of HLA-DRB1 Susceptibility Alleles on the Clinical Subphenotypes of Systemic Lupus Erythematosus in Koreans | 최찬범 |
2015-03 | An Internet-based technique for the identification of persons with symptoms of inflammatory polyarthritis of less than 12 weeks | 최찬범 |
2013-10 | Is Isoniazid Treatment For LTBI Safe For RA Patients With TNF Inhibitor Therapy? | 최찬범 |
2018-09 | Isoniazid treatment for latent tuberculosis infection is tolerable for rheumatoid arthritis patients receiving tumor necrosis factor inhibitor therapy | 최찬범 |
2014-06 | KOREAN BIOLOGICS REGISTRY OF PATIENTS WITH SYSTEMIC RHEUMATIC DISEASE (KOBIO): A NATIONWIDE REGISTRY TO ASSESS ADVERSE EVENTS ASSOCIATED WITH BIOLOGIC TREATMENT IN KOREA | 최찬범 |